The estimate of a pregnant woman's due date can go amiss from a few days, or even several weeks in some cases. Now, a recent study, published on Oct. 28, 2015 in BJOG: An International Journal of Obstetrics and Gynaecology, shows that a screening test involving the use of ultrasound to determine cervical length can help in a more precise prediction of when a woman would give birth. The time frame can be reduced to one week from the time of the screening.
The US Food and Drug Administration (FDA) has given their sign of approval on Tuesday, Oct. 27, to Amgen's Imlygic (talimogene laherparepvec), a cancer immunotherapy against the dreaded melanoma lesions found in the skin and lymph nodes.
